Efficacy of transcranial alternating current stimulation on cognitive function in patients with dementia: a systematic review and meta-analysis of randomized controlled trials.
Ying Tang, Yunhang Wang, Wenyuan Li, Rong Su, Tian Gao, Yuxia Ma
{"title":"Efficacy of transcranial alternating current stimulation on cognitive function in patients with dementia: a systematic review and meta-analysis of randomized controlled trials.","authors":"Ying Tang, Yunhang Wang, Wenyuan Li, Rong Su, Tian Gao, Yuxia Ma","doi":"10.1007/s10072-026-09406-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Transcranial alternating current stimulation (tACS) has shown potential for improving cognitive function in dementia, but evidence remains inconsistent. This systematic review and meta-analysis aims to evaluate the efficacy of tACS on cognitive function in dementia.</p><p><strong>Methods: </strong>We searched seven databases for randomized controlled trials (RCTs) assessing tACS effects on cognitive function in dementia. Two reviewers independently screened the literature, extracted data, and assessed study quality. A random-effects model was used to calculate standardized mean differences (SMDs) with 95% confidence intervals (CIs). GRADE was used to rate evidence quality.</p><p><strong>Results: </strong>A total of 9 RCTs involving 357 patients with dementia were included. Compared with sham stimulation, tACS significantly improved immediate global cognition (SMD = 0.28; 95% CI [0.01, 0.54]; p = 0.04, I² = 39%), but not at follow-up. tACS also significantly improved immediate recall, delayed recall, and associative memory. Additionally, tACS significantly enhanced cholinergic transmission as measured by short-latency afferent inhibition (MD = 0.34, p < 0.001, I² = 0%). However, no significant effect was observed for neuropsychiatric symptoms, and the evidence for executive function was inconclusive. No serious adverse events occurred.</p><p><strong>Conclusion: </strong>tACS may improve immediate global cognition and memory in patients with dementia, but no significant benefit was observed at follow-up or for neuropsychiatric symptoms. Findings are limited by few studies, heterogeneous parameters, and insufficient follow-up data. Future large, well-designed RCTs with standardized protocols are needed to optimize tACS parameters and confirm sustained efficacy.</p>","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":"47 10","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10072-026-09406-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Transcranial alternating current stimulation (tACS) has shown potential for improving cognitive function in dementia, but evidence remains inconsistent. This systematic review and meta-analysis aims to evaluate the efficacy of tACS on cognitive function in dementia.
Methods: We searched seven databases for randomized controlled trials (RCTs) assessing tACS effects on cognitive function in dementia. Two reviewers independently screened the literature, extracted data, and assessed study quality. A random-effects model was used to calculate standardized mean differences (SMDs) with 95% confidence intervals (CIs). GRADE was used to rate evidence quality.
Results: A total of 9 RCTs involving 357 patients with dementia were included. Compared with sham stimulation, tACS significantly improved immediate global cognition (SMD = 0.28; 95% CI [0.01, 0.54]; p = 0.04, I² = 39%), but not at follow-up. tACS also significantly improved immediate recall, delayed recall, and associative memory. Additionally, tACS significantly enhanced cholinergic transmission as measured by short-latency afferent inhibition (MD = 0.34, p < 0.001, I² = 0%). However, no significant effect was observed for neuropsychiatric symptoms, and the evidence for executive function was inconclusive. No serious adverse events occurred.
Conclusion: tACS may improve immediate global cognition and memory in patients with dementia, but no significant benefit was observed at follow-up or for neuropsychiatric symptoms. Findings are limited by few studies, heterogeneous parameters, and insufficient follow-up data. Future large, well-designed RCTs with standardized protocols are needed to optimize tACS parameters and confirm sustained efficacy.
期刊介绍:
Neurological Sciences is intended to provide a medium for the communication of results and ideas in the field of neuroscience. The journal welcomes contributions in both the basic and clinical aspects of the neurosciences. The official language of the journal is English. Reports are published in the form of original articles, short communications, editorials, reviews and letters to the editor. Original articles present the results of experimental or clinical studies in the neurosciences, while short communications are succinct reports permitting the rapid publication of novel results. Original contributions may be submitted for the special sections History of Neurology, Health Care and Neurological Digressions - a forum for cultural topics related to the neurosciences. The journal also publishes correspondence book reviews, meeting reports and announcements.